RBC Capital raised the firm’s price target on MasterCard (MA) to $650 from $572 and keeps an Outperform rating on the shares after its Q4 earnings beat. There was little debate regarding the quarter ...
Narwhal Capital Management cut its stake in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 5.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the ...
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price target hoisted by equities researchers at UBS Group from $162.00 to $176.00 in a research note issued to investors on ...